AgeX Therapeutics Q1 EPS $(0.09) Down From $(0.07) YoY, Sales $10.00K Up From $5.00K YoY
Author: Happy Mohamed | May 12, 2023 04:07pm
AgeX Therapeutics (AMEX:
AGE) reported quarterly losses of $(0.09) per share. This is a 28.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $10.00 thousand in sales this quarter. This is a 100.00 percent increase over sales of $5.00 thousand the same period last year.
Posted In: AGE